Datamonitor, Oct 2010, Pages: 342
UK
APPENDIX C
Contributing experts
Report methodology Pipeline and Commercial Insight: Pneumococcal and Meningococcal Vaccines
Arrowhead Publishers, Jan 2007, Pages: 158
: Competitive Landscape and PipelineInsight” the value of this market is set to reach more than $16 billion in 2006. This growth will continue in the coming years, boosted by a number of new MAbs
Datamonitor, Dec 2010
The "PipelineInsight: Cancer Overview – Breast and Gynecological Cancers" report is due to be published in December 2010.
This report will cover the following key topics:
- Pipeline Overview
Decision Resources, Inc., March 2009, Pages: 24
pipelines and technological innovation that can drive drug discovery.
Get the Answers You Need to Shape Your Strategy
- Big Pharma is continuing the trend of acquiring of biotech companies; overall, life
Datamonitor, July 2010, Pages: 284
Executive Summary
Strategic scoping and focus
Datamonitor insight into the disease market
Related reports
Upcoming related reports
1. Pipeline Overview and Dynamics
Key findings
Pipeline overview
Datamonitor, Dec 2010, Pages: 416
and focus
Datamonitor insight into the disease market
1. Pipeline Overview and Dynamics
Key findings
Pipeline overview
Increase in development candidates as western world focuses on diabetes
Non
Datamonitor, Jan 2011, Pages: 273
.
- Discussion of R&D dynamics and pipeline trends in the neuropathic pain market.- Commercial and clinical assessment of key late-stage pipeline drugs with country-specific sales forecasts to 2019.
- Insight
Spectra Intelligence, April 2006, Pages: 369
and more promising clinical outcome.
In this report, Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities, the reader
Informa Healthcare, Jan 2007, Pages: 175
of therapeutic vaccines
Figure 1.4 Trends in the development of recombinant vaccines
Vaccines Market Insight: Products, Pipelines & Market Outlook
GlobalData, Nov 2011, Pages: 16
InsightMRI - Product Pipeline Analysis
Summary
InsightMRI is a privately held medical device company, principally engaged in providing medical devices for the diagnostic imaging markets
Datamonitor, Sep 2010, Pages: 29
in 2019.
Reasons to Purchase
- Understand patient population dynamics
- Gain insight into the unmet needs of current testosterone treatment and to what extent pipeline drugs will address
Datamonitor, May 2010, Pages: 166
in epilepsy, 2010
Figure 34: Possible inhibition of kindling progression by 2-deoxy-D-glucose in epilepsy
Figure 35: Design of adenosine-releasing implants
PipelineInsight: Epilepsy - Past successes hard
Datamonitor, Sep 2010, Pages: 125
sales reaching nearly $6 billion by 2019. Pipeline candidates will make up 30% of sales in 2019, with once-weekly GLP-1 agonists and new long-acting insulin analogs meeting success.
Scope
- Description
Datamonitor, July 2010, Pages: 257
price to remove impact of currency fluctuations on future trend Pipeline and Commercial Insight: Insomnia - Future of Innovative Orexin Drug Class in Doubt
Datamonitor, July 2010, Pages: 163
-stage migraine prophylaxis pipeline therapies
List of Figures
Figure 41: Methodology for forecasting price to remove impact of currency fluctuations on future trend
Pipeline and Commercial Insight
Datamonitor, April 2008, Pages: 205
in nosocomial vaccine development.
- Gain insight into the pipeline through a discussion of key candidates in clinical development for five nosocomial pathogens.
- Understand and identify key market opportunities
Datamonitor, March 2010, Pages: 238
, including trial data, SWOT analysis and clinical and commercial potential
-Segmentation and analysis of the leukemia pipeline by developmental phase, class and indication
-Insight and analysis of leukemia
Datamonitor, July 2010, Pages: 220
of antihistamines in the UK, , Q3 2006-Q4 2009 and Q3 2002-Q4 2005
Figure 89: Methodology for forecasting price to remove impact of currency fluctuations on trend
Pipeline and Commercial Insight: Allergic
